Skip to content

Agilon Health AGL Free cash flow

Free cash flow at other companies

CVS Health logo
CVS HealthCVS
$3.4B-10.8%
Astrana Health logo
Astrana HealthASTH
$64.06M+372%
Alignment Healthcare logo
Alignment HealthcareALHC
$121.32M+1,350%
Clover Health Investments logo
Clover Health InvestmentsCLOV
$107.04M+750%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-$34.92M-507%
Elevance Health logo
Elevance HealthELV
$4.1B+399%

Other financials

Income statement

See full
Revenue$1.4B-7.3%
Operating income$4.0M+118%
Net income$48.9M+304%
EPS (diluted)$2.94+303%

Balance sheet

See full
Cash & equivalents$211.6M+52.6%
Total debt$33.4M-20.5%
Total equity$181.4M-63.7%
Total assets$1.5B-22.1%

Cash flow

See full
Operating cash flow$23.7M+174%
CapEx$3.1M-19.4%

Valuation

See full
Market cap$1.86B-92.6%
Enterprise value$1.69B-103%
P/S0.3×-3.9×

Profitability

See full
Operating margin-7.5%+6.5pp
Net margin-6.1%+6.3pp
FCF margin-1.1%

Returns & leverage

See full
Return on equity-104%-291pp
Debt / equity0.2×+0.1×
Current ratio-0.2×

Where this comes from

Calculated from Agilon Health’s reported figures.

The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilon Health's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agilon Health's free cash flow?
Agilon Health (AGL) reported free cash flow of $20.63M in Q1 2026.
How has Agilon Health's free cash flow changed year-over-year?
Agilon Health's free cash flow increased by 157.6% year-over-year, from -$35.84M to $20.63M.
What is the long-term trend for Agilon Health's free cash flow?
Over 3 years (2021 to 2025), Agilon Health's free cash flow has grown at a -8.4% compound annual growth rate (CAGR), from -$154.72M to -$119.01M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.